| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9de52bba13e16028dffa8775e3f3f28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2020-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a0180ee5aec66cd4c3b6889228d6ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db3226c09222c555bada7e71b177013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f284d417057641349b607916836690f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3867fef9885581fd007b24177a147671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ef8aee24566986bf8b12b51b53a550
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1849e5d34f3bfa2c9cdbadebf34c9f |
| publicationDate |
2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111999508-A |
| titleOfInvention |
Diagnostic marker and application thereof in COVID-19 diagnosis and coronavirus past infection detection |
| abstract |
The invention discloses a diagnostic marker and application thereof in COVID-19 diagnosis and previous infection detection of coronavirus. The diagnostic marker comprises a peptide fragment COVID19-V001, and the amino acid sequence of the peptide fragment COVID19-V001 is as follows: a sequence comprising 5 and more than 5 contiguous amino acids in FKEELDKYFKNH; or the amino acid sequence of the peptide fragment COVID19-V001 is as follows: comprises a sequence formed by substitution or/and deletion or/and addition of 1 to several amino acids in FKEELDKYFKNH. Based on the diagnostic marker, the level of IgG antibody of the anti-peptide segment in human serum is qualitatively detected by an indirect method. The detection kit established based on the invention can be used as an auxiliary means for diagnosing the novel coronavirus pneumonia (COVID-19). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022177520-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112646006-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112646006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113308560-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113248580-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113092780-A |
| priorityDate |
2020-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |